Adefovir-induced Fanconi syndrome associated with osteomalacia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Samel | - |
dc.contributor.author | Kim, Woo-Il | - |
dc.contributor.author | Cho, Dai-Hyun | - |
dc.contributor.author | Kim, Yeo-Joo | - |
dc.contributor.author | Kim, Hong-Soo | - |
dc.contributor.author | Kim, Ji-Hee | - |
dc.contributor.author | Cha, Seung-Kuy | - |
dc.contributor.author | Park, Kyu-Sang | - |
dc.contributor.author | Lee, Ji-Hye | - |
dc.contributor.author | Lee, Sang Mi | - |
dc.contributor.author | Lee, Eun Young | - |
dc.date.accessioned | 2021-08-11T11:43:58Z | - |
dc.date.available | 2021-08-11T11:43:58Z | - |
dc.date.issued | 2018-09 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5692 | - |
dc.description.abstract | Fanconi syndrome is a dysfunction of the proximal renal tubules that results in impaired reabsorption and increased urinary loss of phosphate and other solutes. The pathophysiology of drug-induced Fanconi syndrome is unclear. Here we report the case of a 36-year-old woman who presented with pain in multiple bones and proteinuria. She had a 7-year history of taking adefovir at 10 mg/day for chronic hepatitis B. Three years previously she had received surgery for a nontraumatic right femur neck fracture, after which she continued to complain of pain in multiple bones, and proteinuria, glycosuria, and phosphaturia were noted. The findings of a light-microscope examination of a renal biopsy sample were normal, but mitochondrial damage of the proximal tubules was evident in electron microscopy. Western blot analysis revealed that the level of serum fibroblast growth factor 23 (FGF23) was lower than in normal controls. After 2 months of treatment, hypophosphatemia and proximal tubular dysfunction were reversed, and serum FGF23 had normalized. This case suggests that direct mitochondrial damage in proximal tubules can cause drug-induced Fanconi syndrome associated with osteomalacia. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한간학회 | - |
dc.title | Adefovir-induced Fanconi syndrome associated with osteomalacia | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3350/cmh.2017.0009 | - |
dc.identifier.scopusid | 2-s2.0-85059476833 | - |
dc.identifier.wosid | 000444861200011 | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.24, no.3, pp 339 - 344 | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 24 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 339 | - |
dc.citation.endPage | 344 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002384296 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | GROWTH-FACTOR 23 | - |
dc.subject.keywordPlus | HEPATITIS-B | - |
dc.subject.keywordPlus | DIPIVOXIL | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | FGF23 | - |
dc.subject.keywordAuthor | Adefovir | - |
dc.subject.keywordAuthor | Fanconi syndrome | - |
dc.subject.keywordAuthor | Mitochondria | - |
dc.subject.keywordAuthor | Proximal tubules | - |
dc.subject.keywordAuthor | Osteomalacia | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.